Aveanna Healthcare Holdings Inc. (AVAH) shares surged 9.96% in pre-market trading on Thursday following the release of its impressive first-quarter 2025 financial results and an upward revision of its full-year guidance.
The home healthcare provider reported Q1 revenue of $559.2 million, significantly surpassing the analyst consensus estimate of $513.1 million. This represents a robust 14% increase compared to the same period last year. The company's adjusted EBITDA also outperformed expectations, coming in at $67.4 million versus the forecasted $39.9 million.
Adding to the positive sentiment, Aveanna raised its full-year 2025 outlook. The company now projects revenue to exceed $2.15 billion, up from its previous guidance range of $2.10 - $2.12 billion. Additionally, the adjusted EBITDA forecast was increased to over $207 million, a substantial improvement from the earlier projected range of $190 - $194 million. This upward revision in guidance signals management's confidence in the company's growth trajectory and operational efficiency.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。